Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Oncothyreon patents

List of Oncothyreon patents

List of Codiak BioSciences patents

List of Gradalis patents

List of Genelux Corporation patents

List of funding rounds for ReturnLogic

List of companies founded by Siavash Mahdavi

Patents where

Current Assignee

Name

is

Oncothyreon

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7741297 Immunostimulatory, covalently lipidated oligonucleotides	Patent 7741297 was granted and assigned to Oncothyreon on June, 2010 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	7741297	June 22, 2010
	‌ US Patent 8198400 Vaccine for modulating between T1 and T2 immune responses	Patent 8198400 was granted and assigned to Oncothyreon on June, 2012 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	8198400	June 12, 2012
	‌ US Patent 8097593 Lipid A and other carbohydrate ligand analogs	Patent 8097593 was granted and assigned to Oncothyreon on January, 2012 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	8097593	January 17, 2012
	‌ US Patent 9119784 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine	Patent 9119784 was granted and assigned to Oncothyreon on September, 2015 by the United States Patent and Trademark Office.	Oncothyreon	Oncothyreon		United States Patent and Trademark Office	9119784	September 1, 2015
	‌ US Patent 8889616 MUC1 based glycolipopeptide vaccine with adjuvant	Patent 8889616 was granted and assigned to Oncothyreon on November, 2014 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	8889616	November 18, 2014
	‌ US Patent 7820627 Lipid A and other carbohydrate ligand analogs	Patent 7820627 was granted and assigned to Oncothyreon on October, 2010 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	7820627	October 26, 2010
	‌ US Patent 8871250 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine	Patent 8871250 was granted and assigned to Oncothyreon on October, 2014 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	8871250	October 28, 2014
	‌ US Patent 9173929 Mucinous glycoprotein (MUC-1) vaccine	Patent 9173929 was granted and assigned to Oncothyreon on November, 2015 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	9173929	November 3, 2015
	‌ US Patent 8552145 Vaccine for modulating between T1 and T2 immune responses	Patent 8552145 was granted and assigned to Oncothyreon on October, 2013 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	8552145	October 8, 2013
	‌ US Patent 8329639 MUC1 based glycolipopeptide vaccine with adjuvant	Patent 8329639 was granted and assigned to Oncothyreon on December, 2012 by the United States Patent and Trademark Office.		Oncothyreon		United States Patent and Trademark Office	8329639	December 11, 2012

10 results

0 selected

10 results

0 selected